Background: The pleiotropic effects of
HMG-CoA reductase inhibitors (statins) have been under investigation in recent
years and include improvement of endothelial dysfunction, increased nitric
oxide bioavailability, antioxidant properties, inhibition of inflammatory
responses, and stabilization of atherosclerotic disease. Additionally, statins
have recently been shown to decrease the incidence of VTE in the general
population (Glynn RJ et al. NEJM 2009). Our aim in this study was to evaluate
the effect of statin use on the incidence of VTE in patients with cancer.
Methods: We performed a chart review of
patients diagnosed with cancer in 2006 and 2007 at the Milwaukee Veterans
Affairs hospital and identified those who developed a VTE. We also identified
patients who were undergoing statin therapy (st+ve) and those not on a statin
(st-ve). St+ve was defined as either on a statin at the time of a VTE or 3
consecutive months of use at any point in time in those without a VTE.
Proportions were compared using the chi-square test. Survival was analyzed
using the Kaplan-Meier estimates and was compared using the log rank test.
Results: Of the 1,175 patients
identified, the median age was 65 (25-96), 1,148 were male (98%), and 548 (47%)
had received statin therapy. The primary sites of cancer were genito-urinary
(40%), lung (20%), gastrointestinal (12%), head/neck (8%), hematological
malignancies (5%), liver/pancreas (4%), skin (4%), caner of unknown primary
site (3%) and other cancers (4%). Overall, 90 (7.7%) had a documented VTE. The
incidence of VTE was 4.7% and 10.2% in st+ve and st- ve patients respectively
(p = <0.001). The median survival for all patients was 1300 days. The median
survival for patients with and without a VTE was 474 days and 1,300 days
respectively (p = <0.0001). The median survival for st-ve and st+ve patients
was 980 days and 1300 days respectively (p = 0.001).
Conclusions: Statins decrease the
incidence of VTE in cancer patients and may additionally provide a survival
benefit. These results should be confirmed in large randomized prospective studies.